Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank67
3Y CAGR-36.0%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-36.0%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.00-33.6%
20240.00+22.1%
20230.00-67.6%
20220.01-
20210.00-
20200.00-
20190.00-
20180.00-
20170.00-
20160.00-